BLDAVCZELRQXFP-OWOJBTEDSA-N

BLDAVCZELRQXFP-OWOJBTEDSA-N Structure
CAS No.
1803026-58-5
Chemical Name:
BLDAVCZELRQXFP-OWOJBTEDSA-N
Synonyms
Sitagliptin Impurity 02;BLDAVCZELRQXFP-OWOJBTEDSA-N;Sitagliptin Styrylacetyl Analogue;Sitagliptin USP Styrylacetyl Analog;(E)-Sitagliptin Styrylacetyl Analog;Sitagliptin Tablets EP Impurity FP-C;Sitagliptin Impurity G (styryl acetyl analogue);Sitagliptin Impurity 14 (Sitagliptin Tablets EP Impurity FP-C);Sitagliptin Styrylacetyl Analog (Sitagliptin FP Impurity C/ 3-Desamino-3,4-Dehydro Sitagliptin);3-Buten-1-one, 1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3E)-
CBNumber:
CB43154838
Molecular Formula:
C16H12F6N4O
Molecular Weight:
390.28
MOL File:
1803026-58-5.mol
Modify Date:
2023/5/15 10:43:56

BLDAVCZELRQXFP-OWOJBTEDSA-N Properties

Boiling point 504.1±60.0 °C(Predicted)
Density 1.52±0.1 g/cm3(Predicted)
solubility Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
form Solid
pka -0.05±0.20(Predicted)
color White to Off-White

BLDAVCZELRQXFP-OWOJBTEDSA-N Chemical Properties,Uses,Production

Uses

3-Desamino-3,4-dehydro Sitagliptin is an impurity of Sitagliptin (S491000); a trizolopyrazine dipeptidyl peptidase IV inhibitor. Sitagliptin has recently been approved for the therapy of type II diabetes.

BLDAVCZELRQXFP-OWOJBTEDSA-N Preparation Products And Raw materials

Raw materials

Preparation Products

BLDAVCZELRQXFP-OWOJBTEDSA-N Suppliers

Global( 52)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
GLP Pharma Standards +91 9866074638 Hyderabad, India 1644 58 Inquiry
Molsyns Research +91-9586858886 +91-9586858886 Gujarat, India 418 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Chemicea Pharmaceuticals Pvt Ltd +91-9881765045/+91-8796656135 Pune, India 825 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
Career Henan Chemica Co +86-0371-86658258 +8613203830695 China 30253 58 Inquiry
ANHUI WITOP BIOTECH CO., LTD +8615255079626 China 23556 58 Inquiry
sgtlifesciences pvt ltd +8617013299288 China 12382 58 Inquiry
China National Standard Pharmaceutical Corporation Limited +8615391658522 China 11927 58 Inquiry
Sitagliptin impurity 7/Sitagliptin FP Impurity C/Sitagliptin Styryl Analogue/3-Desamino-3,4-Dehydro Sitagliptin/(3E)-1-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)but-3-en-1-on BLDAVCZELRQXFP-OWOJBTEDSA-N Sitagliptin Styrylacetyl Analogue (E)-Sitagliptin Styrylacetyl Analog Sitagliptin USP Styrylacetyl Analog 3-Buten-1-one, 1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3E)- Sitagliptin Impurity 02 Sitagliptin Styrylacetyl Analog (Sitagliptin FP Impurity C/ 3-Desamino-3,4-Dehydro Sitagliptin) Sitagliptin Impurity G (styryl acetyl analogue) Sitagliptin Tablets EP Impurity FP-C (E)-1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one (Sitagliptin Impurity) Sitagliptin Impurity 14 (Sitagliptin Tablets EP Impurity FP-C) 1803026-58-5